PL371364A1 - Corticotropin releasing factor 2 receptor agonists - Google Patents

Corticotropin releasing factor 2 receptor agonists

Info

Publication number
PL371364A1
PL371364A1 PL03371364A PL37136403A PL371364A1 PL 371364 A1 PL371364 A1 PL 371364A1 PL 03371364 A PL03371364 A PL 03371364A PL 37136403 A PL37136403 A PL 37136403A PL 371364 A1 PL371364 A1 PL 371364A1
Authority
PL
Poland
Prior art keywords
receptor agonists
releasing factor
corticotropin releasing
corticotropin
factor
Prior art date
Application number
PL03371364A
Other languages
Polish (pl)
Inventor
Robert Joseph Isfort
Wiesław Adam Mazur
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL371364A1 publication Critical patent/PL371364A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
PL03371364A 2002-01-16 2003-01-16 Corticotropin releasing factor 2 receptor agonists PL371364A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34911702P 2002-01-16 2002-01-16
US37633702P 2002-04-29 2002-04-29
US38889502P 2002-06-14 2002-06-14
US41198802P 2002-09-19 2002-09-19

Publications (1)

Publication Number Publication Date
PL371364A1 true PL371364A1 (en) 2005-06-13

Family

ID=27617822

Family Applications (3)

Application Number Title Priority Date Filing Date
PL03373529A PL373529A1 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists
PL03373139A PL373139A1 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists
PL03371364A PL371364A1 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor 2 receptor agonists

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL03373529A PL373529A1 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists
PL03373139A PL373139A1 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists

Country Status (30)

Country Link
US (7) US7192923B2 (en)
EP (4) EP1465921B1 (en)
JP (3) JP4508648B2 (en)
KR (3) KR100758857B1 (en)
CN (3) CN1617887A (en)
AR (3) AR038144A1 (en)
AT (4) ATE398632T1 (en)
AU (2) AU2003237419B2 (en)
BR (3) BR0306838A (en)
CA (3) CA2470743C (en)
CY (1) CY1106133T1 (en)
DE (4) DE60318547T2 (en)
DK (2) DK1465923T3 (en)
ES (4) ES2287484T3 (en)
HK (1) HK1078095A1 (en)
IL (5) IL162431A0 (en)
MA (3) MA27590A1 (en)
MX (3) MXPA04006885A (en)
MY (1) MY140306A (en)
NO (3) NO20043366L (en)
NZ (3) NZ533599A (en)
PE (3) PE20030747A1 (en)
PL (3) PL373529A1 (en)
PT (2) PT1465921E (en)
RU (1) RU2294333C2 (en)
SA (3) SA03230564B1 (en)
SI (1) SI1465921T1 (en)
TW (3) TW200302278A (en)
WO (3) WO2003062268A2 (en)
ZA (1) ZA200404995B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1319024A2 (en) * 2000-09-22 2003-06-18 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US7192923B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
NZ591415A (en) * 2005-03-30 2012-10-26 Novartis Vaccines & Diagnostic Haemophilus influenzae type B
WO2007090087A2 (en) * 2006-01-27 2007-08-09 Research Development Foundation Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
WO2009040047A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Therapeutic uses of ghrelin and combinations with stresscopin
WO2009046874A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic combination of trh-potentiating peptide and stresscopin
JP5385277B2 (en) * 2007-09-11 2014-01-08 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト Use of proadrenomedullin alone or in combination with big gastrin I as a therapeutic agent
NZ592670A (en) * 2008-11-04 2013-01-25 Janssen Pharmaceutica Nv Corticotrophin releasing hormone receptor 2 peptide agonists and uses thereof
EP2206726A1 (en) * 2009-01-08 2010-07-14 Universite Joseph Fourier Non-invasive tools for detecting vulnerable atherosclerotic plaques
BR112012010661A2 (en) * 2009-11-04 2016-11-22 Janssen Pharmaceutica Nv method for treating heart failure with stressecopine-like peptides
WO2013063046A1 (en) 2011-10-24 2013-05-02 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
PL2814513T3 (en) * 2012-02-14 2018-06-29 The Regents Of The University Of California Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
JOP20170153A1 (en) * 2016-07-15 2019-01-30 Lilly Co Eli Novel fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease
WO2018075973A2 (en) * 2016-10-20 2018-04-26 Cortene Inc. Methods of treating diseases resulting from a maladapted stress response
CN110755434B (en) * 2018-07-27 2022-03-15 中国医学科学院药物研究所 Application of compound palosuran in prevention and treatment of diseases such as skeletal muscle atrophy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
US5786203A (en) * 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
EP0860501A3 (en) 1994-06-14 1999-05-19 Neurocrine Biosciences, Inc. Corticotropin-releasing factor2 receptors
US5824771A (en) 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US5663292A (en) 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
JP2002504802A (en) 1995-06-13 2002-02-12 ザ ソルク インスティテュート フォア バイオロジカル スタディース Urocortin peptide
US5869450A (en) 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
ES2313978T3 (en) 2000-08-04 2009-03-16 Research Development Foundation UROCORTINE PROTEINS AND ITS USES.
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US7192923B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists

Also Published As

Publication number Publication date
PE20030747A1 (en) 2003-10-23
ATE383372T1 (en) 2008-01-15
EP1465921A2 (en) 2004-10-13
KR20040082392A (en) 2004-09-24
BR0306838A (en) 2005-04-05
NO20043366L (en) 2004-10-06
CA2470731A1 (en) 2003-07-31
ZA200404995B (en) 2005-06-29
PE20030849A1 (en) 2003-12-01
NZ533600A (en) 2007-02-23
BR0306878A (en) 2004-10-26
ES2309909T3 (en) 2008-12-16
JP2005525101A (en) 2005-08-25
CA2470656C (en) 2011-06-28
EP1465922B1 (en) 2008-01-09
US20030148958A1 (en) 2003-08-07
US7608701B2 (en) 2009-10-27
WO2003062277A1 (en) 2003-07-31
CN1617885A (en) 2005-05-18
EP1465923B1 (en) 2007-05-16
RU2294333C2 (en) 2007-02-27
ES2287484T3 (en) 2007-12-16
PL373139A1 (en) 2005-08-22
JP4508648B2 (en) 2010-07-21
JP4489434B2 (en) 2010-06-23
TW200302276A (en) 2003-08-01
EP1465922A2 (en) 2004-10-13
CA2470731C (en) 2011-06-21
CA2470743A1 (en) 2003-07-31
EP1465923A1 (en) 2004-10-13
SA03230564A (en) 2005-12-03
EP1465921B1 (en) 2006-07-26
CN100475844C (en) 2009-04-08
US20030148957A1 (en) 2003-08-07
US7632933B2 (en) 2009-12-15
KR20040082390A (en) 2004-09-24
IL162530A0 (en) 2005-11-20
DK1465921T3 (en) 2006-11-27
HK1078095A1 (en) 2006-03-03
DE60307044D1 (en) 2006-09-07
SA03230564B1 (en) 2006-10-31
CY1106133T1 (en) 2011-06-08
US7897731B2 (en) 2011-03-01
EP1724283B1 (en) 2008-06-18
US7192924B2 (en) 2007-03-20
WO2003062269A2 (en) 2003-07-31
JP2005522191A (en) 2005-07-28
NZ533598A (en) 2007-03-30
CN1617887A (en) 2005-05-18
MXPA04006885A (en) 2004-12-06
PT1465923E (en) 2007-08-06
NO20043396L (en) 2004-10-06
CN100391972C (en) 2008-06-04
TW200302277A (en) 2003-08-01
SI1465921T1 (en) 2006-10-31
DE60318547D1 (en) 2008-02-21
IL196384A0 (en) 2011-07-31
DE60318547T2 (en) 2008-12-24
US20090124793A1 (en) 2009-05-14
AR038143A1 (en) 2004-12-29
ES2269976T3 (en) 2007-04-01
EP1724283A3 (en) 2007-04-11
DK1465923T3 (en) 2007-07-02
US7192923B2 (en) 2007-03-20
JP2005521387A (en) 2005-07-21
PT1465921E (en) 2006-12-29
IL162529A0 (en) 2005-11-20
AU2003205197B2 (en) 2006-03-02
CA2470656A1 (en) 2003-07-31
DE60313845T2 (en) 2008-01-31
ES2299701T3 (en) 2008-06-01
US20030148956A1 (en) 2003-08-07
RU2004124847A (en) 2005-04-20
KR100758857B1 (en) 2007-09-14
MXPA04006883A (en) 2004-12-06
CN1617886A (en) 2005-05-18
MXPA04006884A (en) 2004-12-06
EP1724283A2 (en) 2006-11-22
PL373529A1 (en) 2005-09-05
MA27592A1 (en) 2005-11-01
WO2003062269A3 (en) 2003-11-06
JP4508649B2 (en) 2010-07-21
WO2003062268A3 (en) 2003-11-27
AR038142A1 (en) 2004-12-29
BR0306826A (en) 2005-09-06
NZ533599A (en) 2007-03-30
SA03230565B1 (en) 2006-10-31
DE60321730D1 (en) 2008-07-31
KR100758858B1 (en) 2007-09-14
US7462597B2 (en) 2008-12-09
TWI300442B (en) 2008-09-01
MY140306A (en) 2009-12-31
IL197774A0 (en) 2009-12-24
US6936585B2 (en) 2005-08-30
MA27591A1 (en) 2005-11-01
US20100197579A1 (en) 2010-08-05
KR20040082389A (en) 2004-09-24
DE60307044T2 (en) 2007-02-15
MA27590A1 (en) 2005-11-01
US20060025339A1 (en) 2006-02-02
CA2470743C (en) 2011-12-13
ATE398632T1 (en) 2008-07-15
DE60313845D1 (en) 2007-06-28
ATE334147T1 (en) 2006-08-15
SA03230565A (en) 2005-12-03
US20080004435A1 (en) 2008-01-03
WO2003062268A2 (en) 2003-07-31
PE20030974A1 (en) 2003-12-26
AU2003237419B2 (en) 2006-04-13
ATE362488T1 (en) 2007-06-15
IL162431A0 (en) 2005-11-20
TW200302278A (en) 2003-08-01
NO20043371L (en) 2004-10-06
KR100735586B1 (en) 2007-07-04
AR038144A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
IL197774A0 (en) Corticotropin releasing factor 2 receptor agonists
EP1482895A4 (en) Aminoalkylphosphonates and related compounds as edg receptor agonists
AP1916A (en) Purine compounds and use thereof as cannabinoid receptor ligands
IL150632A0 (en) Corticotropin releasing factor antagonists
EP1482896A4 (en) Aminoalkylphosphonates and related compounds as edg receptor agonists
EP1559422A4 (en) Receptor function controlling agent
HUP0401437A3 (en) Adenosine a3 receptor agonists
AU6497701A (en) Melanocortin receptor agonists
AU2003236205A1 (en) Glucagon antagonists/inverse agonists
AU2002351730A1 (en) Glucagon receptor antagonists/inverse agonists
AU2003248356A1 (en) Beta3-adrenergic receptor agonists
GB0226227D0 (en) Receptors
ZA200404994B (en) Corticotropin releasing factor 2 receptor agonists
SI1465923T1 (en) Corticotropin releasing factor receptor 2 agonists
GB0215389D0 (en) Receptor
AU2003300867A8 (en) Uses of the snorf207 receptor
GB0223399D0 (en) Receptors
AU2002302807A1 (en) Corticotropin releasing factor antagonists
GB0201919D0 (en) A�-Adenosine receptor agonists
GB0201849D0 (en) A�- adenosine receptor agonists
SI1558615T1 (en) Purine compounds and use thereof as cannabinoid receptor ligands
GB0408454D0 (en) Leptin receptor agonists (1)
GB0408398D0 (en) Leptin receptor agonists (3)
GB0302925D0 (en) 4P re use 001
AU2003297644A8 (en) Uses of the snorf55 receptor

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)